Press Release Service
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Main focus: Next-generation gene-editing systems
Company stage: Pre-clinical
Genome editing tool: CRISPR-Cas9, multiple undisclosed
Funding stage: Private
Location: Everyville, CA, USA
Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. The company has yet not disclosed any of its lead programmes, but announced a multi-year, multi-target collaboration with Moderna to develop in vivo gene-editing therapeutics.